Publication
Article
The American Journal of Managed Care
June 2003Volume9 Issue 6
High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Articles in this issue
A Randomized Trial of an Acid-peptic Disease Management Program in a Managed Care Environment
When Money Is Saved by Reducing Healthcare Costs, Where Do US Primary Care Physicians Think the Money Goes?
Care Management Interventions for Older Patients with Congestive Heart Failure
High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
